Attached files
| file | filename |
|---|---|
| EX-31.2 - VITASPRING BIOMEDICAL CO. LTD. | ex312.htm |
| EX-31.1 - VITASPRING BIOMEDICAL CO. LTD. | ex311.htm |
| 10-K - VITASPRING BIOMEDICAL CO. LTD. | vsbcreport10k2020.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the annual report of VitaSpring Biomedical Co. Ltd. (the "Company") on Form 10-K for the year ended January 31, 2020, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Chu Pao-Chi, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and result of
operations of the Company.
|
|
|
|
|
|
|
|
|
| /s/ Chu Pao-Chi |
|
|
|
|
| Chu Pao-Chi |
|
|
|
|
| Chief Executive Officer |
|
|
|
|
| (Principal Executive Officer) |
|
Date: June 9, 2020
A signed original of this written statement required by Section 906 has been provided to VitaSpring Biomedical Co. Ltd. and will be retained by VitaSpring Biomedical Co. Ltd and furnished to the Securities and Exchange Commission or its staff upon request.
The forgoing certification is being furnished to the Securities and Exchange Commission pursuant to § 18 U.S.C. Section 1350. It is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.